DB32871ExperimentalProtein Based Therapies
GA31 is an 31-amino acid TREM-1 inhibitory peptide.
- Mechanism
- Curator reviewed
Pharmacologically active on Triggering receptor expressed on myeloid cells 1
- Also known as
- GA31-LPC
Resolves to
Targets
What you can answer from here — as of July 02, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with GA31, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account